Literature DB >> 18792786

Arm/hand swelling and perceived functioning among breast cancer survivors 12 years post-diagnosis: CALGB 79804.

Jill M Oliveri1, Jeannette M Day, Catherine M Alfano, James E Herndon, Mira L Katz, Marisa A Bittoni, Kathleen Donohue, Electra D Paskett.   

Abstract

INTRODUCTION: Lymphedema is an under-reported and debilitating consequence of axillary node dissection among breast cancer survivors. This study describes the characteristics of arm and hand swelling in relation to perceived physical and mental health functioning among breast cancer survivors 9-16 years post-diagnosis who previously participated in a clinical trial coordinated by the Cancer and Leukemia Group B (CALGB 8541).
METHODS: Eligible survivors of CALGB 8541 completed questionnaires assessing demographics, arm/hand swelling, perceived physical functioning, and mental health.
RESULTS: Two hundred forty-five women (94% white, mean age = 63, on average 12.4 years post-diagnosis) completed questionnaires (participation rate = 78%). Seventy-five women (31%) reported arm/hand swelling since their surgery. Of these women, 76% reported current swelling and half reported constant swelling, mainly in the upper arm. Swelling was reported as mild or moderate in 88% of the women. Women who reported severe swelling had significantly worse physical functioning and trended toward worse depressive symptoms and poorer mental health (lower mental SF-36 scores) as well. Activity-limiting swelling was also significantly associated with worse physical functioning. Although swelling interfered with wearing clothing (36%) and perceptions about general appearance (32%), only 37% of women sought treatment for swelling.
CONCLUSIONS: Arm/hand swelling is a chronic problem for a subgroup of long-term survivors of breast cancer, negatively affecting physical functioning. IMPLICATIONS FOR CANCER SURVIVORS: Educational efforts are needed as part of a comprehensive survivorship care plan to raise awareness about lymphedema so that survivors may identify this complication, seek treatment early, and potentially improve their physical functioning.

Entities:  

Mesh:

Year:  2008        PMID: 18792786      PMCID: PMC3910496          DOI: 10.1007/s11764-008-0065-y

Source DB:  PubMed          Journal:  J Cancer Surviv        ISSN: 1932-2259            Impact factor:   4.442


  38 in total

Review 1.  Health-related quality of life with lymphoedema: a review of the literature.

Authors:  Philip A Morgan; Peter J Franks; Christine J Moffatt
Journal:  Int Wound J       Date:  2005-03       Impact factor: 3.315

Review 2.  Incidence of breast carcinoma-related lymphedema.

Authors:  J A Petrek; M C Heelan
Journal:  Cancer       Date:  1998-12-15       Impact factor: 6.860

3.  Arm edema after treatment for breast cancer.

Authors:  H I Guedes Neto
Journal:  Lymphology       Date:  1997-03       Impact factor: 1.286

Review 4.  Lymphedema: current issues in research and management.

Authors:  J A Petrek; P I Pressman; R A Smith
Journal:  CA Cancer J Clin       Date:  2000 Sep-Oct       Impact factor: 508.702

5.  Comparison of pain, motion, and edema after modified radical mastectomy vs. local excision with axillary dissection and radiation.

Authors:  L Gerber; M Lampert; C Wood; M Duncan; T D'Angelo; W Schain; H McDonald; D Danforth; P Findlay; E Glatstein
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

6.  Lymphedema: Knowledge, Treatment, and Impact Among Breast Cancer Survivors.

Authors:  Electra D. Paskett; Nancy Stark
Journal:  Breast J       Date:  2000-11       Impact factor: 2.431

7.  Maintaining mobility in late life. I. Demographic characteristics and chronic conditions.

Authors:  J M Guralnik; A Z LaCroix; R D Abbott; L F Berkman; S Satterfield; D A Evans; R B Wallace
Journal:  Am J Epidemiol       Date:  1993-04-15       Impact factor: 4.897

8.  Risk of lymphoedema following the treatment of breast cancer.

Authors:  M W Kissin; G Querci della Rovere; D Easton; G Westbury
Journal:  Br J Surg       Date:  1986-07       Impact factor: 6.939

9.  Cosmetic and functional outcomes of breast conserving treatment for early stage breast cancer. 2. Relationship with psychosocial functioning.

Authors:  K C Sneeuw; N K Aaronson; J R Yarnold; M Broderick; J Regan; G Ross; A Goddard
Journal:  Radiother Oncol       Date:  1992-11       Impact factor: 6.280

10.  Lymphedema after treatment of breast cancer.

Authors:  Cihangir Ozaslan; Bekir Kuru
Journal:  Am J Surg       Date:  2004-01       Impact factor: 2.565

View more
  10 in total

Review 1.  Psychosocial impact of lymphedema: a systematic review of literature from 2004 to 2011.

Authors:  Mei R Fu; Sheila H Ridner; Sophia H Hu; Bob R Stewart; Janice N Cormier; Jane M Armer
Journal:  Psychooncology       Date:  2012-10-09       Impact factor: 3.894

2.  The psychosocial impact of lymphedema-related distress among breast cancer survivors in the WHEL Study.

Authors:  Sally A Dominick; Loki Natarajan; John P Pierce; Hala Madanat; Lisa Madlensky
Journal:  Psychooncology       Date:  2014-02-26       Impact factor: 3.894

3.  Pain in long-term breast cancer survivors: frequency, severity, and impact.

Authors:  Mark P Jensen; Hao-Yuan Chang; Yeur-Hur Lai; Karen L Syrjala; Jesse R Fann; Julie R Gralow
Journal:  Pain Med       Date:  2010-06-08       Impact factor: 3.750

4.  Lymphatic mapping and preoperative imaging in the management of post-mastectomy lymphoedema.

Authors:  Muhammed Chowdhry; Warren Matthew Rozen; Matthew Griffiths
Journal:  Gland Surg       Date:  2016-04

5.  Priorities for women with lymphoedema after treatment for breast cancer: population based cohort study.

Authors:  Afaf Girgis; Fiona Stacey; Teresa Lee; Deborah Black; Sharon Kilbreath
Journal:  BMJ       Date:  2011-06-21

6.  Race or Resource? BMI, Race, and Other Social Factors as Risk Factors for Interlimb Differences among Overweight Breast Cancer Survivors with Lymphedema.

Authors:  Lorraine T Dean; Anagha Kumar; Taehoon Kim; Matthew Herling; Justin C Brown; Zi Zhang; Margaret Evangelisti; Renata Hackley; Jiyoung Kim; Andrea Cheville; Andrea B Troxel; J Sanford Schwartz; Kathryn H Schmitz
Journal:  J Obes       Date:  2016-06-28

7.  SF-36 Shows Increased Quality of Life Following Complete Reduction of Postmastectomy Lymphedema with Liposuction.

Authors:  Mattias Hoffner; Shirin Bagheri; Emma Hansson; Jonas Manjer; Thomas Troëng; Håkan Brorson
Journal:  Lymphat Res Biol       Date:  2017-01-30       Impact factor: 2.589

8.  Health-related quality of life outcomes for the LEAP study-CALGB 70305 (Alliance): A lymphedema prevention intervention trial for newly diagnosed breast cancer patients.

Authors:  Michelle J Naughton; Heshan Liu; Drew K Seisler; Jennifer Le-Rademacher; Jane M Armer; Jill M Oliveri; Jeffrey A Sloan; Karen Hock; Michael Schwartz; Gary Unzeitig; Marianne Melnik; Lisa D Yee; Gini F Fleming; John R Taylor; Charles Loprinzi; Electra D Paskett
Journal:  Cancer       Date:  2020-10-20       Impact factor: 6.860

9.  Improving the quality of life of patients with breast cancer-related lymphoedema by lymphaticovenous anastomosis (LVA): study protocol of a multicentre randomised controlled trial.

Authors:  Joost Wolfs; Jop Beugels; Merel Kimman; Andrzej A Piatkowski de Grzymala; Esther Heuts; Xavier Keuter; Hanneke Tielemans; Dietmar Ulrich; R van der Hulst; Shan Shan Qiu
Journal:  BMJ Open       Date:  2020-01-15       Impact factor: 2.692

Review 10.  Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.

Authors:  Suzanne A Eccles; Eric O Aboagye; Simak Ali; Annie S Anderson; Jo Armes; Fedor Berditchevski; Jeremy P Blaydes; Keith Brennan; Nicola J Brown; Helen E Bryant; Nigel J Bundred; Joy M Burchell; Anna M Campbell; Jason S Carroll; Robert B Clarke; Charlotte E Coles; Gary J R Cook; Angela Cox; Nicola J Curtin; Lodewijk V Dekker; Isabel dos Santos Silva; Stephen W Duffy; Douglas F Easton; Diana M Eccles; Dylan R Edwards; Joanne Edwards; D Evans; Deborah F Fenlon; James M Flanagan; Claire Foster; William M Gallagher; Montserrat Garcia-Closas; Julia M W Gee; Andy J Gescher; Vicky Goh; Ashley M Groves; Amanda J Harvey; Michelle Harvie; Bryan T Hennessy; Stephen Hiscox; Ingunn Holen; Sacha J Howell; Anthony Howell; Gill Hubbard; Nick Hulbert-Williams; Myra S Hunter; Bharat Jasani; Louise J Jones; Timothy J Key; Cliona C Kirwan; Anthony Kong; Ian H Kunkler; Simon P Langdon; Martin O Leach; David J Mann; John F Marshall; Lesley Martin; Stewart G Martin; Jennifer E Macdougall; David W Miles; William R Miller; Joanna R Morris; Sue M Moss; Paul Mullan; Rachel Natrajan; James P B O'Connor; Rosemary O'Connor; Carlo Palmieri; Paul D P Pharoah; Emad A Rakha; Elizabeth Reed; Simon P Robinson; Erik Sahai; John M Saxton; Peter Schmid; Matthew J Smalley; Valerie Speirs; Robert Stein; John Stingl; Charles H Streuli; Andrew N J Tutt; Galina Velikova; Rosemary A Walker; Christine J Watson; Kaye J Williams; Leonie S Young; Alastair M Thompson
Journal:  Breast Cancer Res       Date:  2013-10-01       Impact factor: 6.466

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.